Skip to content
6-K

Foreign Interim / Material

Ping An Biomedical Co., Ltd. PASW

0001213900-25-093049

← back to feed
Filed
Sep 29, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q2 2025 · Mar 31, 2025 18M sh
Shares Diluted Q2 2025 · Mar 31, 2024 18M sh
Operating Cash Flow Q2 2025 · Mar 31, 2025 $34.6K
Operating Cash Flow Q2 2025 · Mar 31, 2025 ¥251.04K
Operating Cash Flow Q2 2025 · Mar 31, 2024 ¥3.85M
Short Term Debt Q2 2025 · Mar 31, 2025 $1.38M
Short Term Debt Q2 2025 · Mar 31, 2025 ¥10M
Short Term Debt Q2 2025 · Sep 30, 2024 ¥10M
Cash And Equivalents Q2 2025 · Mar 31, 2025 $15.11K
Cash And Equivalents Q2 2025 · Mar 31, 2025 ¥109.65K
Cash And Equivalents Q2 2025 · Sep 30, 2024 ¥130.92K
Stockholders Equity Q2 2025 · Mar 31, 2025 −$1.62M
Stockholders Equity Q2 2025 · Mar 31, 2025 −¥11.75M
Stockholders Equity Q2 2025 · Sep 30, 2024 −¥7.19M
Stockholders Equity Q2 2025 · Mar 31, 2024 −¥5.56M
Stockholders Equity Q2 2025 · Sep 30, 2023 −¥5.86M
Current Liabilities Q2 2025 · Mar 31, 2025 $8.28M
Current Liabilities Q2 2025 · Mar 31, 2025 ¥60.08M
Current Liabilities Q2 2025 · Sep 30, 2024 ¥63.58M
Total Liabilities Q2 2025 · Mar 31, 2025 $8.32M
Total Liabilities Q2 2025 · Mar 31, 2025 ¥60.37M
Total Liabilities Q2 2025 · Sep 30, 2024 ¥64.04M
Current Assets Q2 2025 · Mar 31, 2025 $6.35M
Current Assets Q2 2025 · Mar 31, 2025 ¥46.07M
Current Assets Q2 2025 · Sep 30, 2024 ¥53.31M
Total Assets Q2 2025 · Mar 31, 2025 $6.7M
Total Assets Q2 2025 · Mar 31, 2025 ¥48.63M
Total Assets Q2 2025 · Sep 30, 2024 ¥56.85M
Eps Diluted Q2 2025 · Mar 31, 2025 −$0.03
Eps Diluted Q2 2025 · Mar 31, 2025 −¥0.24
Eps Diluted Q2 2025 · Mar 31, 2024 −¥0.01
Eps Basic Q2 2025 · Mar 31, 2025 −$0.03
Eps Basic Q2 2025 · Mar 31, 2025 −¥0.24
Eps Basic Q2 2025 · Mar 31, 2024 −¥0.01
Sga Expense Q2 2025 · Mar 31, 2025 $364.9K
Sga Expense Q2 2025 · Mar 31, 2025 ¥2.65M
Sga Expense Q2 2025 · Mar 31, 2024 ¥2.58M
Net Income Q2 2025 · Mar 31, 2025 −$583.34K
Net Income Q2 2025 · Mar 31, 2025 −¥4.23M
Net Income Q2 2025 · Mar 31, 2024 ¥237.7K
Operating Income Q2 2025 · Mar 31, 2025 −$498.51K
Operating Income Q2 2025 · Mar 31, 2025 −¥3.62M
Operating Income Q2 2025 · Mar 31, 2024 ¥1.1M
Gross Profit Q2 2025 · Mar 31, 2025 −$95.4K
Gross Profit Q2 2025 · Mar 31, 2025 −¥692.32K
Gross Profit Q2 2025 · Mar 31, 2024 ¥3.68M
Cost Of Revenue Q2 2025 · Mar 31, 2025 $2.61M
Cost Of Revenue Q2 2025 · Mar 31, 2025 ¥18.92M
Cost Of Revenue Q2 2025 · Mar 31, 2024 ¥42.04M
Revenue Q2 2025 · Mar 31, 2025 $2.51M
Revenue Q2 2025 · Mar 31, 2025 ¥18.23M
Revenue Q2 2025 · Mar 31, 2024 ¥45.72M